Read the accompanying story from The Atlantic.
Kathleen Conneally successfully quit smoking after a decades-long habit with the help of psilocybin. Conneally was a participant in a study at Johns Hopkins University looking at whether nicotine addiction could be treated by psilocybin, the active compound in magic mushrooms. In this short video, staff writer Olga Khazan speaks with Conneally about her experience and uncovers the science of how psychedelics work in the brain to make this possible.
New York University Psilocybin Music Sampler That Helps Patients with Psychological Distress
Psychedelic Stroke of Insight for Smoking Cessation
Psychedelic Medicines Want to Help a Broken and Addicted U.S. Mental Health Care System
Could Psilocybin Be Useful in Combating Depression and Anxiety in Homebound Older Adults and Patients with Chronic or Terminal Illness?
FDA-Approved Drug Therapies and Classic Hallucinogens to Treat Addiction: Barriers, Background, and the Latest Research
America's Top Psychiatrist Shares His Thoughts on Psychedelics
American Ethnobotanists Richard Evans Schultes, Dennis McKenna Discuss Hallucinogenic Plant Medicines, More
Early Life Stress Major Risk Factor for Adult Depression, Adolescent Depression and Early Life Stress Linked to Impaired Reward Circuits Important in Addiction